Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07113106
What this trial is testing

Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteers
ANRS, Emerging Infectious Diseases 48
Not applicableStudy completedNCT06381843
What this trial is testing

A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 120
Early research (Phase 1)Active Not RecruitingNCT07183709
What this trial is testing

Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT05781191
What this trial is testing

Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine

Who this might be right for
InfluenzaCOVID-19
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 8,231
Large-scale testing (Phase 3)Study completedNCT05975060
What this trial is testing

Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.

Who this might be right for
COVID-19
Novavax 660
Not applicableStudy completedNCT05285384
What this trial is testing

Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine

Who this might be right for
COVID-19
Cinnagen 43
Early research (Phase 1)Study completedNCT05260437
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 99
Not applicableUnknownNCT06303635
What this trial is testing

Safety of UFRJvac, Trivalent COVID-19 Vaccine

Who this might be right for
Healthy People
Azidus Brasil 156
Large-scale testing (Phase 3)Study completedNCT04887948
What this trial is testing

Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

Who this might be right for
Pneumococcal DiseaseCOVID-19SARS-CoV-2 Infection
Pfizer 570
Testing effectiveness (Phase 2)Study completedNCT05576623
What this trial is testing

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 320
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Testing effectiveness (Phase 2)Study completedNCT05205096
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Not applicableEnded earlyNCT05142540
What this trial is testing

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines

Who this might be right for
Anti-SARS-CoV-2 Antibody Response
Medical University of Graz 140
Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT04895449
What this trial is testing

Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19

Who this might be right for
Covid19
Universitätsklinikum Hamburg-Eppendorf 43
Not applicableStudy completedNCT05907044
What this trial is testing

Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

Who this might be right for
COVID-19
Affiliated Hospital of Yunnan University 376
Not applicableUnknownNCT05571657
What this trial is testing

COVID-19 Booster Dose Reminder/Recall for Adolescents

Who this might be right for
COVID-19 Vaccines
Marshfield Clinic Research Foundation 4,304
Large-scale testing (Phase 3)UnknownNCT05405283
What this trial is testing

Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults

Who this might be right for
COVID-19 Vaccines
Assistance Publique - Hôpitaux de Paris 189
Very early researchStudy completedNCT06831786
What this trial is testing

Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers

Who this might be right for
COVID - 19
Prince of Songkla University 36
Testing effectiveness (Phase 2)Study completedNCT05197153
What this trial is testing

Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

Who this might be right for
COVID-19 Vaccine
Medigen Vaccine Biologics Corp. 804
Next Page